Narda Theobald

1.4k total citations
19 papers, 475 citations indexed

About

Narda Theobald is a scholar working on Molecular Biology, Genetics and Immunology. According to data from OpenAlex, Narda Theobald has authored 19 papers receiving a total of 475 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Genetics and 7 papers in Immunology. Recurrent topics in Narda Theobald's work include Virus-based gene therapy research (7 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (6 papers) and CRISPR and Genetic Engineering (5 papers). Narda Theobald is often cited by papers focused on Virus-based gene therapy research (7 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (6 papers) and CRISPR and Genetic Engineering (5 papers). Narda Theobald collaborates with scholars based in United States, Germany and United Kingdom. Narda Theobald's co-authors include Harry L. Malech, Uimook Choi, Elizabeth M. Kang, Gilda F. Linton, Debra A. Long Priel, Suk See De Ravin, Paul Gardner, Xiaolin Wu, Colin L. Sweeney and Sherry Koontz and has published in prestigious journals such as Blood, Journal of Virology and Journal of Neurochemistry.

In The Last Decade

Narda Theobald

19 papers receiving 470 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Narda Theobald United States 10 297 208 150 108 68 19 475
Claudia Firrito Italy 4 393 1.3× 224 1.1× 70 0.5× 108 1.0× 50 0.7× 8 515
Geoffrey L. Rogers United States 14 426 1.4× 431 2.1× 160 1.1× 278 2.6× 96 1.4× 23 738
Saswati Chatterjee United States 13 376 1.3× 340 1.6× 60 0.4× 90 0.8× 63 0.9× 18 516
Hayley E. Raymond United States 6 247 0.8× 201 1.0× 64 0.4× 70 0.6× 90 1.3× 13 451
Xiao Jin Yu United States 4 329 1.1× 338 1.6× 54 0.4× 106 1.0× 33 0.5× 4 438
Samia Martin France 13 375 1.3× 276 1.3× 148 1.0× 82 0.8× 80 1.2× 16 637
Aude Sirven France 3 269 0.9× 255 1.2× 54 0.4× 57 0.5× 49 0.7× 3 389
Sohel Talib United States 14 192 0.6× 79 0.4× 236 1.6× 131 1.2× 38 0.6× 24 605
Lilith Reeves United States 12 419 1.4× 352 1.7× 39 0.3× 135 1.3× 69 1.0× 22 535
Ekaterini Kotsopoulou United Kingdom 11 329 1.1× 178 0.9× 63 0.4× 193 1.8× 42 0.6× 13 507

Countries citing papers authored by Narda Theobald

Since Specialization
Citations

This map shows the geographic impact of Narda Theobald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Narda Theobald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Narda Theobald more than expected).

Fields of papers citing papers by Narda Theobald

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Narda Theobald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Narda Theobald. The network helps show where Narda Theobald may publish in the future.

Co-authorship network of co-authors of Narda Theobald

This figure shows the co-authorship network connecting the top 25 collaborators of Narda Theobald. A scholar is included among the top collaborators of Narda Theobald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Narda Theobald. Narda Theobald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Ma, Linyuan, Siyuan Liu, Madelynn N. Whittaker, et al.. (2024). High-fidelity PAMless base editing of hematopoietic stem cells to treat chronic granulomatous disease. Science Translational Medicine. 16(769). eadj6779–eadj6779. 7 indexed citations
2.
3.
Sweeney, Colin L., Mara Pavel-Dinu, Uimook Choi, et al.. (2021). Correction of X-CGD patient HSPCs by targeted CYBB cDNA insertion using CRISPR/Cas9 with 53BP1 inhibition for enhanced homology-directed repair. Gene Therapy. 28(6). 373–390. 34 indexed citations
4.
Vetharoy, Winston, Uimook Choi, Christine Rivat, et al.. (2021). Preclinical Optimization and Safety Studies of a New Lentiviral Gene Therapy for p47 phox -Deficient Chronic Granulomatous Disease. Human Gene Therapy. 32(17-18). 949–958. 4 indexed citations
5.
Parta, Mark, Dianne Hilligoss, Corin Kelly, et al.. (2020). Failure to Prevent Severe Graft-Versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide in Chronic Granulomatous Disease. Journal of Clinical Immunology. 40(4). 619–624. 11 indexed citations
6.
7.
Parta, Mark, Corin Kelly, Nana Kwatemaa, et al.. (2017). Allogeneic Reduced-Intensity Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease: a Single-Center Prospective Trial. Journal of Clinical Immunology. 37(6). 548–558. 33 indexed citations
8.
Parta, Mark, Dianne Hilligoss, Corin Kelly, et al.. (2015). Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide in a Patient with Chronic Granulomatous Disease and Active Infection: A First Report. Journal of Clinical Immunology. 35(7). 675–680. 26 indexed citations
9.
Ravin, Suk See De, Andreas Reik, Peiqi Liu, et al.. (2015). 54. Genome Editing of Primary Human CD34+ Hematopoietic Stem Cells Enables a Safe Harbor Targeted Gene Addition Therapeutic Strategy for Chronic Granulomatous Disease. Molecular Therapy. 23. S24–S24. 1 indexed citations
10.
11.
Ravin, Suk See De, Xiaolin Wu, Narda Theobald, et al.. (2015). Lentiviral Hematopoietic Stem Cell Gene Therapy for Older Patients with X-Linked Severe Combined Immunodeficiency. Blood. 126(23). 261–261. 3 indexed citations
12.
Ravin, Suk See De, Ling Su, Narda Theobald, et al.. (2014). Enhancers Are Major Targets for Murine Leukemia Virus Vector Integration. Journal of Virology. 88(8). 4504–4513. 80 indexed citations
13.
Merling, Randall K., Colin L. Sweeney, Uimook Choi, et al.. (2013). Transgene-free iPSCs generated from small volume peripheral blood nonmobilized CD34+ cells. Blood. 121(14). e98–e107. 70 indexed citations
14.
15.
Kang, Elizabeth M., Uimook Choi, Narda Theobald, et al.. (2009). Retrovirus gene therapy for X-linked chronic granulomatous disease can achieve stable long-term correction of oxidase activity in peripheral blood neutrophils. Blood. 115(4). 783–791. 117 indexed citations
16.
Kang, Elizabeth M., et al.. (2008). Treatment of infections in patients with X-linked chronic granulomatous disease (CGD) with gene therapy. Blood Cells Molecules and Diseases. 40(2). 270–271. 1 indexed citations
17.
Kang, Elizabeth M., et al.. (2007). Treatment of Infections in Patients with X-Linked Chronic Granulomatous Disease (XCGD) with Gene Therapy.. Blood. 110(11). 504–504. 1 indexed citations
18.
Gao, Zhigang, Mary Jo Fackler, Wing Leung, et al.. (2001). Human CD34+ cell preparations contain over 100-fold greater NOD/SCID mouse engrafting capacity than do CD34− cell preparations. Experimental Hematology. 29(7). 910–921. 45 indexed citations
19.
Hu, Minjie, Narda Theobald, & Paul Gardner. (1994). Rapid Communication: Nerve Growth Factor Increases the Transcriptional Activity of the Rat Neuronal Nicotinic Acetylcholine Receptor β4 Subunit Promoter in Transfected PC12 Cells. Journal of Neurochemistry. 62(1). 392–395. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claudia Firrito Breakdown of academic impact, for papers by Geoffrey L. Rogers Breakdown of academic impact, for papers by Saswati Chatterjee Breakdown of academic impact, for papers by Hayley E. Raymond Breakdown of academic impact, for papers by Xiao Jin Yu Breakdown of academic impact, for papers by Samia Martin Breakdown of academic impact, for papers by Aude Sirven Breakdown of academic impact, for papers by Sohel Talib Breakdown of academic impact, for papers by Lilith Reeves Breakdown of academic impact, for papers by Ekaterini Kotsopoulou
Rankless by CCL
2026